Quest Laborato.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0TNW01017
NSEID: QUESTLAB
BSEID:

INR

101.00

1 (1.0%)

BSENSE

Dec 29

BSE+NSE Vol: 13200

{
  "main_header": {
    "sid": 10039259,
    "name": "Quest Laborato.",
    "stock_name": "Quest Laborato.",
    "full_name": "Quest Laboratories Ltd",
    "name_url": "stocks-analysis/quest-laborato",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "101.00",
    "chg": 1,
    "chgp": "1.0%",
    "dir": 1,
    "prev_price": "100.00",
    "mcapval": "164.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "QUESTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0TNW01017",
    "curr_date": "Dec 29",
    "curr_time": "",
    "bse_nse_vol": 13200,
    "exc_status": "Active",
    "traded_date": "Dec 29, 2025",
    "traded_date_str": "2025 12 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/quest-laborato-10039259-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Quest Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/quest-laboratories-ltd-is-rated-sell-3769062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/QuestLaboratori_mojoScore_3769062.png",
        "date": "2025-12-25 12:58:29",
        "description": "Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Why is Quest Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-quest-laboratories-ltd-fallingrising-3767673",
        "imagepath": "",
        "date": "2025-12-24 02:33:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Rally Contrasted by Longer-Term Weakness</strong></p>\n<p>Quest Laboratories has delivered impressive returns over the past week and month, with gains of 17.44% and 16.49% respectively. These figures significantly outpace the Sensex, which rose by 1.23% over the week and 0.42% over the month. Such short-term momentum suggests renewed investor interest and positive sentiment in the near term.</p>\n<p>However, this recent rally contrasts sharply with the stock’s year-to-date and one-year performance. The stock has declined by 16.27% year-to-date and 7.78% over the last twelve months, while the Sensex has gained 10.71% and 10.20% over the same periods. This divergence indicates that despite recent enthusiasm, Quest Laboratories has struggled to keep pace with broader market gains over ..."
      },
      {
        "title": "Quest Laborato. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/quest-laborato-upgraded-to-sell-rating-by-marketsmojo-amid-mixed-fundamentals-3748234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/QuestLaborato_mojoScore_3748234.png",
        "date": "2025-12-05 10:10:27",
        "description": "Quest Laborato., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics. This shift reflects a nuanced reassessment of the company’s fundamentals, valuation, financial trends, and technical outlook, providing investors with fresh insights into its current standing amid challenging market conditions."
      },
      {
        "title": "Quest Laboratories Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/quest-laboratories-faces-severe-selling-pressure-amid-prolonged-downtrend-3721434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/QuestLaboratori_only_sellers_3721434.png",
        "date": "2025-11-21 15:50:20",
        "description": "Quest Laboratories Ltd is experiencing significant selling pressure, with the stock registering a decline of 2.19% today and showing no buying interest. This persistent downward momentum reflects distress selling signals as the stock continues to underperform both its sector and the broader market indices."
      },
      {
        "title": "Quest Laboratories Q2 FY26: Margin Pressures Mount Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/quest-laboratories-q2-fy26-margin-pressures-mount-despite-revenue-growth-3708053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/QuestLaboratori_quaterlyResult_3708053.png",
        "date": "2025-11-15 11:22:22",
        "description": "Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹143.00 crores, reported mixed results for Q2 FY26, with net profit of ₹4.02 crores declining 1.95% quarter-on-quarter whilst declining 33.66% year-on-year. The stock has faced significant headwinds, trading at ₹86.00 and down 25.61% over the past year, substantially underperforming the broader pharmaceuticals sector which gained 4.05% during the same period."
      },
      {
        "title": "How has been the historical performance of Quest Laborato.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-quest-laborato-3704338",
        "imagepath": "",
        "date": "2025-11-15 00:34:46",
        "description": "Answer:\nThe historical performance of Quest Laborato shows significant growth in various financial metrics over the past few years.\n\nBreakdown:\nQuest Laborato's net sales have increased from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also rose from 0.53 Cr in Mar'23 to 87.93 Cr in Mar'25, indicating increased operational costs. Operating profit (PBDIT) grew from 0.09 Cr in Mar'23 to 20.22 Cr in Mar'25, showcasing improved profitability, while profit before tax increased from 0.07 Cr in Mar'23 to 18.68 Cr in Mar'25. Profit after tax also saw a substantial rise from 0.05 Cr in Mar'23 to 13.57 Cr in Mar'25. On the balance sheet, total assets grew from 46.94 Cr in Mar'23 to 121.65 Cr in Mar'25, with total liabilities..."
      },
      {
        "title": "Why is Quest Laborato. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-quest-laborato-fallingrising-3699951",
        "imagepath": "",
        "date": "2025-11-14 00:05:55",
        "description": "As of 13-Nov, Quest Laboratories Ltd is experiencing a price increase, with its current price at 94.70, reflecting a change of 6.05 or 6.82% upward. The stock has shown strong performance today, outperforming its sector by 6.67%. Additionally, it has gained 10.05% over the past week and 7.61% over the past month, although it has underperformed on a year-to-date basis with a decline of 21.77%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but below its 200-day moving average. However, there is a notable decline in investor participation, as the delivery volume has fallen by 81.01% compared to the 5-day average, indicating a potential concern for future trading activity. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement.\n\nBroader market context shows that while Quest Laboratories Ltd has outperfo..."
      },
      {
        "title": "How has been the historical performance of Quest Laborato.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-quest-laborato-3699845",
        "imagepath": "",
        "date": "2025-11-13 23:52:41",
        "description": "Answer:\nThe historical performance of Quest Laborato shows significant growth in net sales and profitability over the past few years.\n\nBreakdown:\nQuest Laborato's net sales have increased dramatically from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 59.48 Cr in Mar'22 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also grew, reaching 87.98 Cr in Mar'25 from 53.02 Cr in Mar'22. Operating profit (PBDIT) has shown consistent improvement, climbing from 6.52 Cr in Mar'22 to 20.22 Cr in Mar'25, while profit before tax increased from 5.77 Cr in Mar'22 to 18.68 Cr in Mar'25. Consequently, profit after tax rose from 4.11 Cr in Mar'22 to 13.57 Cr in Mar'25. The company's total assets have expanded significantly, from 34.80 Cr in Mar'22 to 121.65 Cr in Mar'25, while total liabilities also..."
      },
      {
        "title": "Why is Quest Laborato. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-quest-laborato-fallingrising-3596981",
        "imagepath": "",
        "date": "2025-10-06 23:45:11",
        "description": "As of 06-Oct, Quest Laboratories Ltd is experiencing a decline in its stock price, currently at 90.05, which represents a decrease of 4.4 or 4.66%. The stock has underperformed its sector by 4.77% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 4.25%, and it has seen a significant drop of 25.61% year-to-date. While there has been a notable increase in investor participation, with delivery volume rising by 238.71% against the 5-day average, the overall performance remains weak, and there are no positive or negative dashboard factors available to provide further context on the stock's movement.\n\nIn the broader market context, the Sensex has shown a positive return of 1.80% over the past week, contrasting sharply with Quest Laboratories' decline. This underperformance highlights the stock's struggle relative to the b..."
      }
    ],
    "total": 116,
    "sid": "10039259",
    "stock_news_url": "https://www.marketsmojo.com/news/quest-laboratories-10039259"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Quest Laboratories Ltd is Rated Sell

2025-12-25 12:58:29

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Why is Quest Laboratories Ltd falling/rising?

2025-12-24 02:33:44

Short-Term Rally Contrasted by Longer-Term Weakness

Quest Laboratories has delivered impressive returns over the past week and month, with gains of 17.44% and 16.49% respectively. These figures significantly outpace the Sensex, which rose by 1.23% over the week and 0.42% over the month. Such short-term momentum suggests renewed investor interest and positive sentiment in the near term.

However, this recent rally contrasts sharply with the stock’s year-to-date and one-year performance. The stock has declined by 16.27% year-to-date and 7.78% over the last twelve months, while the Sensex has gained 10.71% and 10.20% over the same periods. This divergence indicates that despite recent enthusiasm, Quest Laboratories has struggled to keep pace with broader market gains over ...

Quest Laborato. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-05 10:10:27

Quest Laborato., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics. This shift reflects a nuanced reassessment of the company’s fundamentals, valuation, financial trends, and technical outlook, providing investors with fresh insights into its current standing amid challenging market conditions.

Quest Laboratories Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-11-21 15:50:20

Quest Laboratories Ltd is experiencing significant selling pressure, with the stock registering a decline of 2.19% today and showing no buying interest. This persistent downward momentum reflects distress selling signals as the stock continues to underperform both its sector and the broader market indices.

Quest Laboratories Q2 FY26: Margin Pressures Mount Despite Revenue Growth

2025-11-15 11:22:22

Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹143.00 crores, reported mixed results for Q2 FY26, with net profit of ₹4.02 crores declining 1.95% quarter-on-quarter whilst declining 33.66% year-on-year. The stock has faced significant headwinds, trading at ₹86.00 and down 25.61% over the past year, substantially underperforming the broader pharmaceuticals sector which gained 4.05% during the same period.

How has been the historical performance of Quest Laborato.?

2025-11-15 00:34:46

Answer: The historical performance of Quest Laborato shows significant growth in various financial metrics over the past few years. Breakdown: Quest Laborato's net sales have increased from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also rose from 0.53 Cr in Mar'23 to 87.93 Cr in Mar'25, indicating increased operational costs. Operating profit (PBDIT) grew from 0.09 Cr in Mar'23 to 20.22 Cr in Mar'25, showcasing improved profitability, while profit before tax increased from 0.07 Cr in Mar'23 to 18.68 Cr in Mar'25. Profit after tax also saw a substantial rise from 0.05 Cr in Mar'23 to 13.57 Cr in Mar'25. On the balance sheet, total assets grew from 46.94 Cr in Mar'23 to 121.65 Cr in Mar'25, with total liabilities...

Why is Quest Laborato. falling/rising?

2025-11-14 00:05:55

As of 13-Nov, Quest Laboratories Ltd is experiencing a price increase, with its current price at 94.70, reflecting a change of 6.05 or 6.82% upward. The stock has shown strong performance today, outperforming its sector by 6.67%. Additionally, it has gained 10.05% over the past week and 7.61% over the past month, although it has underperformed on a year-to-date basis with a decline of 21.77%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but below its 200-day moving average. However, there is a notable decline in investor participation, as the delivery volume has fallen by 81.01% compared to the 5-day average, indicating a potential concern for future trading activity. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement. Broader market context shows that while Quest Laboratories Ltd has outperfo...

How has been the historical performance of Quest Laborato.?

2025-11-13 23:52:41

Answer: The historical performance of Quest Laborato shows significant growth in net sales and profitability over the past few years. Breakdown: Quest Laborato's net sales have increased dramatically from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 59.48 Cr in Mar'22 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also grew, reaching 87.98 Cr in Mar'25 from 53.02 Cr in Mar'22. Operating profit (PBDIT) has shown consistent improvement, climbing from 6.52 Cr in Mar'22 to 20.22 Cr in Mar'25, while profit before tax increased from 5.77 Cr in Mar'22 to 18.68 Cr in Mar'25. Consequently, profit after tax rose from 4.11 Cr in Mar'22 to 13.57 Cr in Mar'25. The company's total assets have expanded significantly, from 34.80 Cr in Mar'22 to 121.65 Cr in Mar'25, while total liabilities also...

Why is Quest Laborato. falling/rising?

2025-10-06 23:45:11

As of 06-Oct, Quest Laboratories Ltd is experiencing a decline in its stock price, currently at 90.05, which represents a decrease of 4.4 or 4.66%. The stock has underperformed its sector by 4.77% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 4.25%, and it has seen a significant drop of 25.61% year-to-date. While there has been a notable increase in investor participation, with delivery volume rising by 238.71% against the 5-day average, the overall performance remains weak, and there are no positive or negative dashboard factors available to provide further context on the stock's movement. In the broader market context, the Sensex has shown a positive return of 1.80% over the past week, contrasting sharply with Quest Laboratories' decline. This underperformance highlights the stock's struggle relative to the b...

View All News